Taken together, these results suggest that variation in TSPYL1 expression, Wnt/β-catenin signaling and CYP expression may all contribute to risk for or variation in response to the treatment of obesity. The gene discussed is TSPYL1; the disease is obesity due to melanocortin 4 receptor deficiency.